{
  "Variants Include": [
    {
      "Gene": "α-Synuclein (SNCA)",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "A30P, E46K, and A53T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease (PD)",
    "MONDO": "MONDO:0003948"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro cleavage and fibrillization assay",
      "Material used": {
        "Material Source": "In vitro",
        "Material Name": "αSyn",
        "Description": "αSyn wildtype and mutant (A30P, E46K, A53T) were used in the assay."
      },
      "Readout type": "Qualitative/Quantitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "The 20S proteasome produced C-terminal fragments from both the mutant and wildtype αSyn. These truncations accelerated fibrillization of all α-synucleins."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "N.D."
      }
    }
  ]
}